Table 3.
Reference | Body weight (kg) | BMI (kg/m2) | WC (cm) | Body fat | Other outcomes | ||||
---|---|---|---|---|---|---|---|---|---|
Mean/SD | Mean /SD | Mean/SD | Mean/SD | ||||||
CRD | CRD-PP | CRD | CRD-PP | CRD | CRD-PP | CRD | CRD-PP | ||
Ibero-Baraibar et al. (32) | −2.5* | −2.7* | −0.9* | −1.0* | −4.3* | −5.2* | −1.3* BF% −1.9* TF% |
−1.5* BF% −2.74* TF% |
↔ glucose, insulin, LDL, HDL, TG ↓ oxLDL greater in CRD-PP |
Mielgo-Ayuso et al. (33) | −7.7* | −7.6* | −3.0* | −3.0* | −4.0* | −5.0* | −4.6* BF | −4.9* BF |
↔ fat oxidation, glucose, insulin, TC, HDL, LDL, CRP, RMR, IR. |
Silver et al. (34) | −6.7*/ 3.1 |
Gf:−5.8*/3.1 Gfj:−5.9*/3.6 |
−2.1* /1.1 |
Gf:−1.6*/1.6 Gfj:−1.9*/1.4 |
−5.4* /4.8 |
Gf: - 4.0*/4.1 Gfj:−5.5*/4.7 |
−1.2*/2.6 BF% −1.2*/2.6 TF% |
Gf:−1.1*/1.8 BF% Gfj:−1.1*/1.9 BF% Gf:−1.4*/2.9 TF% Gfj:−1.7*/2.6 TF% |
↔ appetite, glucose, insulin, REE, RQ, IR, BP, TC, LDL, BLM. ⊑ HDL greater in Gfj. |
Diepvens et al. (35) | −4.19*
/1.3 |
−4.21* /2.7 |
−1.5* | −1.5* | −3.6* | −4.5* | −3.9* BF | −3.8* BF |
↔ REE, RQ, SBP, DBP, HR. ⊑ appetite only in CRD-PP. |
BF, total body fat mass (kg); BF%, total body fat percentage; BLM, body lean mass; BMI, body mass index; BP, blood pressure; CRD, calorie restricted diet intervention group; CRD-PP, calorie restricted plus polyphenol intervention group(s); CRP, C-reactive protein; DBP, diastolic blood pressure; Gf, grapefruit; Gfj, grapefruit juice; HDL, high density lipoprotein cholesterol; HR, heart rate; IR, insulin resistance; LDL, low density lipoprotein cholesterol; oxLDL, oxidized low density lipoprotein cholesterol; REE, resting energy expenditure; RMR, resting metabolic rate; RQ, respiratory quotient; SBP, systolic blood pressure; SD, standard deviation; TC, total cholesterol; TF%, trunk fat percentage; WC, waist circumference.
Significant changes within group (p ≤ 0.05).
Significant increase within group (p ≤ 0.05).
Significant decrease within group (p ≤ 0.05).
Not significant changes between groups (CRD-PP vs CRD, p > 0.05).